CGT

60개 · ADC 890 · Antibody 4071 · CGT 2714 · 다음 갱신 D-5 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved60 programs
CGTLimited DatastaleImmune Cell, Inc.Phase 1

ICAR30 T cells (ICAR30 T cells)

Hodgkin Lymphoma; Anaplastic Large Cell Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20 (Infusion of 4SCAR-T specific to CD22/CD123/CD38/ CD10/CD20)

CD19 Negative B-cell Malignancies · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleNanjing Legend Biotech Co.Phase 1

LUCAR-G79 T cells (LUCAR-G79 T cells)

Relapsed/Refractory Autoimmune Diseases · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Preclinical

Lentiviral TYF-ARSA correction of patient's autologous HSCs (Lentiviral TYF-ARSA correction of patient's autologous HSCs)

Metachromatic Leukodystrophy (MLD) · Metachromatic Leukodystrophy (MLD)

#MetachromaticLeukodystrophyMLD#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

NG2 and DLL3 CAR-T cells (NG2 and DLL3 CAR-T cells)

Melanoma · Melanoma

#Melanoma#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
CGTLimited DatastaleTimmune Biotech Inc.Phase 1

Novel CAR-T (Novel CAR-T)

B-cell Non Hodgkin Lymphoma; B-cell Acute Lymphoblastic Leukemia · B-cell Non Hodgkin Lymphoma

#B-cellNonHodgkinLymphoma#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Active
CGTLimited DatastaleCancer Institute and Hospital, …Phase 1

IDOV-Immune (Oncolytic Virus injection, Oncolytic Virus injection(IDOV-Immune))

Cancer · Cancer

#Cancer#CGT#Phase1#cell-gene-therapy#CAR-T+1
Trials 1Status Active
CGTLimited DatastalePell Bio-Med Technology Co., Lt…Preclinical

Pell's lentiviral-based gene-edited immune cell therapy (Pell's lentiviral-based gene-edited immune cell therapy)

Diffuse Large B Cell Lymphoma; Large B-cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Preclinical

Therapeutic 4SCAR19 cells (Therapeutic 4SCAR19 cells)

B-cell Malignancies · B-cell Malignancies

#B-cellMalignancies#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Discontinued
CGTLimited DatastaleTimmune Biotech Inc.Phase 2

TriCAR-T-CD19 (TriCAR-T-CD19)

Non-hodgkin Lymphoma,B Cell · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+4
Trials 1Status Active
CGTLimited DatastaleThe Children's Hospital of Zhej…Phase 1

UCAR T-cell (UCAR T-cell)

Autoimmune Diseases; Systemic Lupus Erthematosus (SLE) · Autoimmune Diseases

#AutoimmuneDiseases#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleBioray LaboratoriesPhase 1

Universal BCMA-CD19 CART (Universal BCMA-CD19 CART)

Autoimmune Disease · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 1

Universal CD19-specific CAR gene-engineered T cells (Universal CD19-specific CAR gene-engineered T cells)

B Cell Malignancies · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 1

Universal CD7-specific CAR gene-engineered T cells (Universal CD7-specific CAR gene-engineered T cells)

T-cell Acute Lymphoblastic Leukemia; T-cell Acute Lymphoblastic Lymphoma · T-cell Acute Lymphoblastic Leukemia

#T-cellAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleRui Therapeutics Co., LtdPhase 1

anti-CD19/BCMA U CAR T (anti-CD19/BCMA U CAR T)

Relapsed/Refractory Immune Nephropathy; Relapsed/Refractory Immune-mediated Kidney Disease · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

bi-4SCAR CD19/79b T cells (bi-4SCAR CD19/79b T cells)

B Cell Malignancies · CD19

#CD19#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

bi-4SCAR GD2/CD70 T cells (bi-4SCAR GD2/CD70 T cells)

Cancer Disease · GD2

#GD2#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

bi-4SCAR PSMA/CD70 T cells (bi-4SCAR PSMA/CD70 T cells)

Cancer Disease · PSMA

#PSMA#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 2

fetal MSCs combined with 4SCAR T cells (fetal MSCs combined with 4SCAR T cells)

Autoimmune Diseases · Autoimmune Diseases

#AutoimmuneDiseases#CGT#Phase2#cell-gene-therapy#CAR-T+2
Trials 1Status Recruiting
CGTLimited DatastaleShenzhen Geno-Immune Medical In…Phase 1

prophylactic 4SCAR19 cells (prophylactic 4SCAR19 cells)

B Acute Lymphoblastic Leukemia · B Acute Lymphoblastic Leukemia

#BAcuteLymphoblasticLeukemia#CGT#Phase1#cell-gene-therapy#CAR-T+2
Trials 1Status Active

3 / 3 pages

← PreviousNext →